共查询到20条相似文献,搜索用时 9 毫秒
1.
Duan M Kazmierski WM Tallant M Jun JH Edelstein M Ferris R Todd D Wheelan P Xiong Z 《Bioorganic & medicinal chemistry letters》2011,21(21):6381-6385
A novel series of cyclic urea-based CCR5 antagonists was designed aiming to resolve instability issue in the fasted simulated intestinal fluid (FSIF) associated with the acyclic urea moiety in 1. This class of CCR5 compounds demonstrated high antiviral activities against HIV-1 infection in both HOS and PBL assays. Further evaluation of these compounds indicated that 16-R not only substantially enhanced its stability, but also exhibited excellent pharmacokinetics properties. 相似文献
2.
《Bioorganic & medicinal chemistry letters》2014,24(1):108-112
A series of fused bicyclic and urea derivatives of spirocyclic compounds were designed, synthesised and evaluated in vitro as potent CCR1 antagonists. In particular, 4 (7 nM), 44 (1.3 nM), 48 (0.89 nM) and 50 (0.63 nM) were the most potent hCCR1 antagonists in this series of compounds. Moreover, some of these substances demonstrated good rodent cross-over, especially 46 which exhibited very high rat CCR1 binding affinity with an IC50 value of 16 nM. 相似文献
3.
Aiko Nitta Yosuke Iura Hideki Inoue Ippei Sato Koichiro Morihira Hirokazu Kubota Tatsuaki Morokata Makoto Takeuchi Mitsuaki Ohta Shin-ichi Tsukamoto Takayuki Imaoka Toshiya Takahashi 《Bioorganic & medicinal chemistry letters》2012,22(22):6876-6881
Optimization starting with our lead compound 1 (IC50 = 4.9 nM) led to the identification of pyrrolidinyl phenylurea derivatives. Further modification toward improvement of the bioavailability provided (R)-1-(1-((6-fluoronaphthalen-2-yl)methyl)pyrrolidin-3-yl)-3-(2-(2-hydroxyethoxy)phenyl)urea 32 (IC50 = 1.7 nM), a potent and orally active CCR3 antagonist. 相似文献
4.
Fonquerna S Miralpeix M Pagès L Puig C Cardús A Antón F Vilella D Aparici M Prieto J Warrellow G Beleta J Ryder H 《Bioorganic & medicinal chemistry letters》2005,15(4):1165-1167
The synthesis and structure-activity relationships of piperidinylpyrrolopyridines as potent and selective H(1) antagonists are discussed. It was found that the nature of the acid chain bonded to piperidine was a key feature for maintaining both the duration of action in vivo and lack of sedative properties. 相似文献
5.
Discovery and structure-activity relationships of novel sulfonamides as potent PTP1B inhibitors 总被引:2,自引:0,他引:2
Holmes CP Li X Pan Y Xu C Bhandari A Moody CM Miguel JA Ferla SW De Francisco MN Frederick BT Zhou S Macher N Jang L Irvine JD Grove JR 《Bioorganic & medicinal chemistry letters》2005,15(19):4336-4341
A series of novel sulfonamides containing a single difluoromethylene-phosphonate group were discovered to be potent inhibitors of protein tyrosine phosphatase 1B. Structure-activity relationships around the scaffold were investigated, leading to the identification of compounds with IC50 or Ki values in the low nanomolar range. These sulfonamide-based inhibitors exhibit 100 and 30 times higher inhibitory activity than the corresponding tertiary amines and carboxamides, respectively. 相似文献
6.
Christine Yang Hong C. Shen Zhicai Wu Hong D. Chu Jason M. Cox Jaume Balsells Alejandro Crespo Patricia Brown Beata Zamlynny Judyann Wiltsie Joseph Clemas Jack Gibson Lisa Contino JeanMarie Lisnock Gaochao Zhou Margarita Garcia-Calvo Tom Bateman Ling Xu Peter Sinclair 《Bioorganic & medicinal chemistry letters》2013,23(15):4388-4392
Novel oxazolidinedione analogs were discovered as potent and selective mineralocorticoid receptor (MR) antagonists. Structure–activity relationship (SAR) studies were focused on improving the potency and microsomal stability. Selected compounds demonstrated excellent MR activity, reasonable nuclear hormone receptor selectivity, and acceptable rat pharmacokinetics. 相似文献
7.
Pégurier C Collart P Danhaive P Defays S Gillard M Gilson F Kogej T Pasau P Van Houtvin N Van Thuyne M van Keulen B 《Bioorganic & medicinal chemistry letters》2007,17(15):4228-4231
The discovery and optimization of a novel class of potent CCR3 antagonists is described. Details of synthesis and SAR are given together with some ADME properties of selected compounds. An optimal balance between activities, physicochemical properties, and in vitro metabolic stability was reached by the proper choice of substituents. 相似文献
8.
《Bioorganic & medicinal chemistry letters》2014,24(4):1239-1242
SAR study of 5-aminooctahydrocyclopentapyrrole-3a-carboxamide scaffold led to identification of several CCR2 antagonists with potent activity in both binding and functional assays. Their cardiovascular safety and pharmacokinetic properties were also evaluated. 相似文献
9.
Makoto Ando Etsuko Sekino Yuji Haga Minoru Moriya Masahiko Ito Junko Ito Hisashi Iwaasa Akane Ishihara Akio Kanatani Norikazu Ohtake 《Bioorganic & medicinal chemistry letters》2009,19(17):5186-5190
Novel phenethylpyridone derivatives were identified as potent human melanin-concentrating hormone 1 receptor (MCH-1R) antagonists. A search for surrogates for the 4-(2-aminoethoxy)phenyl moiety of 1 resulted in discovery of 2-[4-(aminomethyl)phenyl]ethyl substructure as in 6a. Successive optimization of the right-hand moiety led to the identification of a number of potent derivatives. 相似文献
10.
Batt DG Houghton GC Roderick J Santella JB Wacker DA Welch PK Orlovsky YI Wadman EA Trzaskos JM Davies P Decicco CP Carter PH 《Bioorganic & medicinal chemistry letters》2005,15(3):787-791
The synthesis and structure-activity relationships of N-arylalkylpiperidylmethyl ureas as antagonists of the CC chemokine receptor-3 (CCR3) are presented. These compounds displayed potent binding to the receptor as well as functional antagonism of eotaxin-elicited effects on eosinophils. 相似文献
11.
Haga Y Mizutani S Naya A Kishino H Iwaasa H Ito M Ito J Moriya M Sato N Takenaga N Ishihara A Tokita S Kanatani A Ohtake N 《Bioorganic & medicinal chemistry》2011,19(2):883-893
The design, synthesis and structure-activity relationships of a novel class of N-phenylpyridone MCH1R antagonists are described. The core part of the N-phenylpyridone structure was newly designed and the side chain moieties that were attached to the core part were extensively explored. As a result of optimization of the N-phenylpyridone leads, we successfully developed the orally available, and brain-penetrable MCH1R selective antagonist 7c, exhibiting excellent anti-obese effect in diet-induced obese (DIO) mice. 相似文献
12.
Yokoyama K Ishikawa N Igarashi S Kawano N Hattori K Miyazaki T Ogino S Matsumoto Y Takeuchi M Ohta M 《Bioorganic & medicinal chemistry》2008,16(14):7021-7032
A new series of quinazolines that function as CCR4 antagonists were discovered during the screening of our corporate compound libraries. Subsequent compound optimization elucidated the structure-activity relationships and led the identification of 2-(1,4'-bipiperidine-1'-yl)-N-cycloheptyl-6,7-dimethoxyquinazolin-4-amine 14a, which showed potent inhibition in the [(35)S]GTPgammaS-binding assay (IC(50)=18nM). This compound also inhibited the chemotaxis of human and mouse CCR4-expressing cells (IC(50)=140nM, 39nM). 相似文献
13.
Takenouchi K Sogawa R Manabe K Saitoh H Gao Q Miura D Ishizuka S 《The Journal of steroid biochemistry and molecular biology》2004,(1-5):31-34
The Vitamin D(3) lactone analogues, (23S)- and (23R)-25-dehydro-1alpha-hydroxyvitamin D(3)-26,23-lactone (TEI-9647 and TEI-9648) are antagonists of the 1alpha,25-dihydroxyvitamin D(3) (1alpha,25-(OH)(2)D(3)) nuclear receptor (VDR)-mediated differentiation of human leukemia (HL-60) cells. In order to clarify the structure-Vitamin D antagonistic activity relationship, we paid attention to the unique lactone moiety of TEI-9647 and TEI-9648: alpha-exo-methylene-gamma-lactone structure. We synthesized the exo-methylene-modified analogues (methylene saturated, endo-methylene, methylene-deleted, methyl-substituted, dimethyl-substituted, methylene-replaced with dimethyl and cyclopropane) and oxygen-modified analogues (oxygen atom replaced with nitrogen and carbon atom) by convergent method using palladium-catalyzed coupling reaction or direct modification of VD(3) skeleton. The antagonistic activity in HL-60 cell differentiation evaluating system of these analogues revealed that any exo-methylene-modified analogues and nitrogen analogue did not have the antagonistic activity, on the other hand carbon analogue did show. The results suggest that "alpha-exo-methylene carbonyl" structure of VD(3) side-chain is crucial for antagonistic activity. The structure is integral building block of many natural products which have interesting biological and it is thought that Michael-type addition of alpha-exo-methylene carbonyl structure with protein nucleophiles such as cysteine would play an important role for the activities. According to this theory, Michael-type reaction of TEI-9647 and TEI-9648 with cysteine residue in protein related to VDR/VDRE-mediated genomic actions such as VDR would be essential step of the antagonistic action. 相似文献
14.
Wacker DA Santella JB Gardner DS Varnes JG Estrella M DeLucca GV Ko SS Tanabe K Watson PS Welch PK Covington M Stowell NC Wadman EA Davies P Solomon KA Newton RC Trainor GL Friedman SM Decicco CP Duncia JV 《Bioorganic & medicinal chemistry letters》2002,12(13):1785-1789
CCR3 antagonist leads with IC(50) values in the microM range were converted into low nM binding compounds that displayed in vitro inhibition of human eosinophil chemotaxis induced by human eotaxin. In particular, 4-benzylpiperidin-1-yl-n-propylureas and erythro-3-(4-benzyl-2-(alpha-hydroxyalkyl)piperidin-1-yl)-n-propylureas (obtained via Beak reaction of N-BOC-4-benzylpiperidine) exhibited single digit nanomolar IC(50) values for CCR3. 相似文献
15.
Shue HJ Chen X Shih NY Blythin DJ Paliwal S Lin L Gu D Schwerdt JH Shah S Reichard GA Piwinski JJ Duffy RA Lachowicz JE Coffin VL Liu F Nomeir AA Morgan CA Varty GB 《Bioorganic & medicinal chemistry letters》2005,15(17):3896-3899
A series of novel five- and six-membered ring urea derivatives have been described as potent and selective NK1 receptor antagonists. Several compounds in this series exhibited good oral activity and brain penetration. Syntheses of these compounds are also described herein. 相似文献
16.
Hiroshi Morimoto Hideshi Shimadzu Toshihiro Hosaka Yasushi Kawase Kosuke Yasuda Kohei Kikkawa Rikako Yamauchi-Kohno Koichiro Yamada 《Bioorganic & medicinal chemistry letters》2002,12(1):81-84
To improve water solubility and to study structure-activity relationships, we modified the structure of the pyrimidine nucleus of each of a series of potent ET(A) antagonists, 3a and 4a, at the 2-position. In a previous study, each of these antagonists showed an extremely high affinity for the ET(A) receptor in porcine aortic membrane (IC(50) 3a; < 0.001 nM, 4a; 0.0039 nM). Two modification methods, one being the addition of organolithium followed by DDQ oxidation and the other being the nucleophilic substitution of 2-(methylsulfonyl)pyrimidine, were applied individually to synthesize 2-substituted-4-sulfonamidopyrimidine derivatives. The introduction of aryl, heteroaryl, alkyl, amino, alkoxy, or alkylthio groups into the 2-position varied the affinity. Derivatives with hydrophilic groups at the 2-position showed higher water solubility but tended to reduce the affinity for the ET(A) receptor. 相似文献
17.
Yang W Wang Y Roberge JY Ma Z Liu Y Michael Lawrence R Rotella DP Seethala R Feyen JH Dickson JK 《Bioorganic & medicinal chemistry letters》2005,15(4):1225-1228
A structure-activity relationship study of the amine portion of the calcilytic compound NPS-2143 resulted in the discovery of substituted 2-benzylpyrrolidines as replacements for the 1,1-dimethyl-2-naphthalen-2-yl-ethylamine. When compared to NPS-2143, a newly discovered compound, 3h, exhibited similar potency as a calcium-sensing receptor (CaR) antagonist and a superior human ether-a-go-go related gene (hERG) profile. 相似文献
18.
Takao Suzuki Minoru Moriya Toshihiro Sakamoto Takuya Suga Hiroyuki Kishino Hidekazu Takahashi Makoto Ishikawa Keita Nagai Yumiko Imai Etsuko Sekino Masahiko Ito Hisashi Iwaasa Akane Ishihara Shigeru Tokita Akio Kanatani Nagaaki Sato Takehiro Fukami 《Bioorganic & medicinal chemistry letters》2009,19(11):3072-3077
Optimization of high-throughput screening hit 1a led to the identification of a novel spiro-piperidine class of melanin-concentrating hormone 1 receptor (MCH-1R) antagonists. Compound 3c was identified as a highly potent and selective MCH-1R antagonist, which has an IC50 value of 0.09 nM at hMCH-1R. The synthesis and structure–activity relationships of the novel spiro-piperidine MCH-1R antagonists are described. 相似文献
19.
Masaki Asada Tetsuo Obitsu Atsushi Kinoshita Yoshihiko Nakai Toshihiko Nagase Isamu Sugimoto Motoyuki Tanaka Hiroya Takizawa Ken Yoshikawa Kazutoyo Sato Masami Narita Shuichi Ohuchida Hisao Nakai Masaaki Toda 《Bioorganic & medicinal chemistry letters》2010,20(8):2639-2643
A series of novel N-acylsulfonamide analogs were synthesized and evaluated for their binding affinity and antagonist activity for the EP3 receptor subtype. Representative compounds were also evaluated for their inhibitory effect on PGE2-induced uterine contraction in pregnant rats. Among those tested, a series of N-acylbenzenesulfonamide analogs were found to be more potent than the corresponding carboxylic acid analogs in both the in vitro and in vivo evaluations. The structure activity relationships (SAR) are also discussed. 相似文献
20.
Xia M Hou C DeMong D Pollack S Pan M Singer M Matheis M Murray W Cavender D Wachter M 《Bioorganic & medicinal chemistry letters》2008,18(24):6468-6470
The synthesis and structure-activity relationship of a series of 7-azaindole piperidine derivatives are described. SAR studies led to the discovery of the potent CCR2 antagonists displaying IC(50) values in the nanomolar range. The representative compound 15 showed reasonable P450 and pharmacokinetics profile. 相似文献